ACM
CNTA

Aquatic Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Aquatic Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$504K Sell
12,699
-57,056
-82% -$1.46M 0.01% 753
2025
Q4 		$1.74M Buy
+69,755
New +$1.77M 0.05% 409

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Aquatic Capital Management's CNTA Position: Q1 2026 in Review

Aquatic Capital Management reduced its Centessa Pharmaceuticals (CNTA) stake by 82% in Q1 2026, selling an estimated $1.46M and leaving 12,699 shares worth $504K. The position accounts for 0.01% of the portfolio, ranked #753.

Aquatic Capital Management first reported a position in CNTA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.74M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Aquatic Capital Management held 12,699 shares of Centessa Pharmaceuticals worth $504K as of Q1 2026.
  • Aquatic Capital Management sold 57,056 Centessa Pharmaceuticals shares in Q1 2026, an estimated $1.46M.
  • Centessa Pharmaceuticals made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #753 holding.
  • Aquatic Capital Management first reported a position in Centessa Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Aquatic Capital Management's Centessa Pharmaceuticals position peaked at $1.74M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.